Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medtronic PLC MDT

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic... see more

Recent & Breaking News (NYSE:MDT)

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Thomson Reuters ONE January 9, 2014

Inspire Medical's STAR Clinical Trial Results Published in The New England Journal of Medicine

Business Wire January 8, 2014

Wall Street Fundamentals Releases New In-Depth Stock Reports on ABT, BSX, MDT and STJ

Accesswire January 7, 2014

Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections

Thomson Reuters ONE January 6, 2014

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

Thomson Reuters ONE January 6, 2014

Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference

Thomson Reuters ONE January 6, 2014

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Thomson Reuters ONE December 17, 2013

Medtronic Announces First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

Thomson Reuters ONE December 9, 2013

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2014

Thomson Reuters ONE December 5, 2013

First U.S. Implants of New Medtronic Deep Brain Stimulation System Advance Ground-Breaking Research Into Brain Activity While Therapy Is Delivered

Thomson Reuters ONE December 5, 2013

Medtronic Announces CE Mark and TGA Listing for the Symplicity Spyral(TM) Multi-Electrode Catheter and Symplicity G3(TM) Generator

Thomson Reuters ONE December 5, 2013

Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference

Thomson Reuters ONE December 4, 2013

Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference

Thomson Reuters ONE November 26, 2013

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

Thomson Reuters ONE November 25, 2013

Valiant 'Mona LSA' Stent Graft System from Medtronic Demonstrates Proof of Concept in Early Feasibility Study

Thomson Reuters ONE November 20, 2013

Medtronic Reports Second Quarter Earnings

Thomson Reuters ONE November 19, 2013

Late Breaking Clinical Trial Results Show Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features

Thomson Reuters ONE November 18, 2013

FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall

Thomson Reuters ONE November 15, 2013

Medtronic to Resume Sales of CoreValve System in Germany

Thomson Reuters ONE November 14, 2013

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014

Thomson Reuters ONE November 11, 2013